IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
Clicks: 195
ID: 117825
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
195 views
24 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #45 of 72 articles by views in Cell
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Aryl hydrocarbon receptor (AHR) activation by tryptophan (Trp) catabolites enhances tumor malignancy and suppresses anti-tumor immunity. The context specificity of AHR target genes has so far impeded systematic investigation of AHR activity and its upstream enzymes across human cancers. A pan-tissue …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (41 words).
Try re-searching for a better abstract.
| Reference Key |
a2020cellil4i1
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sadik A;Somarribas Patterson LF;Öztürk S;Mohapatra SR;Panitz V;Secker PF;Pfänder P;Loth S;Salem H;Prentzell MT;Berdel B;Iskar M;Faessler E;Reuter F;Kirst I;Kalter V;Foerster KI;Jäger E;Guevara CR;Sobeh M;Hielscher T;Poschet G;Reinhardt A;Hassel JC;Zapatka M;Hahn U;von Deimling A;Hopf C;Schlichting R;Escher BI;Burhenne J;Haefeli WE;Ishaque N;Böhme A;Schäuble S;Thedieck K;Trump S;Seiffert M;Opitz CA;; |
| Journal | Cell |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.